| CAS ID: | 923564-51-6 |
| Molecular Formula: | C47H55ClF3N5O6S3 |
| Molecular Weight: | 974.6 g/mol |
| Monoisotopic Mass: | 973.2955 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | A-855071.3 | NAVITOCLAX | ABT-263 | NAVITOCLAX DIHYDROCHLORIDE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1 | See All |
| InChI Key: | JLYAXFNOILIKPP-KXQOOQHDSA-N | |
| Smiles: | CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT03222609 | Disease | Bone marrow fibrosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | July 19, 2017 | Last Verified | March 11, 2019 |
| Sponsor | AbbVie | ||
| PubChem: | 24978538 |
| ChEMBL: | CHEMBL443684 |